Brann Mark R 4
4 · ACADIA PHARMACEUTICALS INC · Filed Jan 6, 2006
Insider Transaction Report
Form 4
Brann Mark R
DirectorPresident & CSO
Transactions
- Sale
Common Stock
2006-01-06$10.08/sh−6,000$60,480→ 377,756 total(indirect: By Trust)
Holdings
- 52,593
Common Stock
Footnotes (1)
- [F1]The sales reported in this Form 4 were effected pursuant to an existing sales plan established under Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.